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ABSTRACT 
 
Influenza A virus (IAV) is one of the most common infectious pathogens in humans and causes considerable 
morbidity and mortality. The recent spread of highly-pathogenic avian IAV H5N1 viruses has reinforced the 
importance of pandemic preparedness. In the pathogenesis of IAV infection, cellular proteases play critical 
roles in the process of viral entry into cells that subsequently leads to tissue damage in the infected organs. 
Since there are no processing protease for the viral membrane fusion glycoprotein hemagglutinin precursor 
(HA0) in IAV, entry of the virus into cells is determined primarily by the host cellular HA0 processing 
proteases  that  proteolytically  activate  membrane  fusion  activity.  HA0  of  seasonal  human  IAV  has  the 
consensus cleavage site motif Q(E)-T/X-R and is selectively processed by at least seven different trypsin-
type processing proteases identified to-date in animal model experiments using mouse-adapted IAV or gene 
expression system in MDCK cells. As is the case for the highly pathogenic avian influenza (HPAI) A virus, 
endoproteolytic  processing  of  the  HA0  occurs  through  ubiquitous  cellular  processing  proteases,  which 
selectively recognize the multi-basic consensus cleavage site motifs, such as R-X-K/R-R, and K-X-K/R-R. 
The cleavage enzymes for the R-X-K/R-R motif, but not K-X-K/R-R motif, have been reported to be furin 
and pro-protein convertase (PC)5/6 in the trans-Golgi network. Here we report new members of type II 
transmembrane serine proteases of the cell membrane, mosaic serine protease large form (MSPL) and its 
splice variant TMPRSS13, which recognize and cleave both R-X-K/R-R and K-X-K/R-R motifs without 
calcium. Furthermore, IAV infection significantly up-regulates a latent ectopic pancreatic trypsin, one of the 
potent HA processing proteases, and pro-matrix metalloprotease-9, in various organs. These proteases may 
synergistically damage the blood-brain barrier in the brain and basement membrane of blood vessels in 
various  organs,  resulting  in  severe  edema  and  multiple  organ  failure.  In  this  review,  we  discuss  these 
proteases as new drug target molecules for IAV treatment acting by inhibition of IAV multiplication and 
prevention of multiple organ failure, other than anti-viral agents, viral neuraminidase inhibitors. 
 
KEYWORDS: Influenza virus, highly pathogenic avian influenza virus, hemagglutinin processing protease, 
tryptase Clara, mini-plasmin, trypsin, TMPRSS-13  
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INTRODUCTION 
 
Post-translational  proteolytic  cleavage  of  precursors  of 
membrane fusion glycoprotein hemagglutinin (HA0) of the 
enveloped influenza A virus (IAV) is a prerequisite for viral 
membrane  fusion  activity  and  virus  entry  into  the  cell 
(Homma  and  Ohuchi,  1973;  Scheid  and  Choppin,  1974; 
Klenk and Rott, 1988; Kido et al, 1999). However, IAV has 
no  HA0  processing  protease  in  its  genes.  Thus,  cellular 
proteolytic conversion of HA0 to HA1 and HA2 subunits is 
indispensable for viral entry and multiplication within the 
infected  host,  and  is  a  major  determinant  of  IAV 
pathogenicity. 
 
To-date,  two  main  HA0  processing  motifs  have  been 
described in IAV. One is the single basic HA0 processing 
motif  Q(E)-T/X-R  sequence  of  human  seasonal  IAVs 
(Klenk and Garten, 1994; Kido et al, 1999), and the R-E-T-
R and P-K-X-R motifs of avirulent avian IAV H5 and H7, 
respectively  (Tsukamoto  et  al,  2008),  which  are  readily 
cleaved  by  several  extracellular  trypsin-type  proteases. 
Among many of the cellular trypsin-type serine proteases, 
only few enzymes selectively convert HA0 to HA1 and HA2. 
In  addition,  the  processing  proteases  for  the  single  basic 
motif  are  predominantly  distributed  in  the  airway  and 
enteric duct, and most of the epidemic human IAV known 
to date are pneumotropic in which the virus proliferates in 
these organs, except for a few neurotropic strains, such as 
IAV WSN/33(H1N1) strain (Ward, 1996). The other HA0 
processing  motif is a multiple-basic-residues motif  of the 
highly  pathogenic avian influenza  (HPAI)  viruses.  In  the 
multiple basic residues motifs, the R-K/R-K/R/X-R  motif 
with  R  at  position  P4  is  readily  cleaved  by  ubiquitously 
present intracellular processing proteases, such as furin and 
proprotein convertases (PCs)5/6, in the presence of calcium 
(Klenk and Garten, 1994; Horimoto et al, 1994; Remacle et 
al, 2008). However, replacement of P4 R by K and a non-
basic  amino  acid  in  the  multi-basic  motif  significantly 
suppresses the processing activities of furin and PCs (Barr, 
1991;  Thomas,  2002;  Remacle  et  al,  2008).  We  recently 
reported  the  identification  of  novel  type  II  membrane 
processing proteases of the cell surface, which preferentially 
cleaved after the carboxy-terminal R residue in the multiple 
basic residues motifs of both R-K/R-K/R/X-R and K-K/R-
K/R/X-R sequences without calcium. 
 
In the progress of IAV pathogenicity, infection results in up-
regulation of host cellular proteases, such as latent ectopic 
pancreatic trypsin and matrix metalloprotease-9 (MMP-9) in 
various  organs,  potentially  causing  damage  of  connective 
tissues and destruction of tight junctions of endothelial cells 
followed by severe edema.  
 
HA0 PROCESSING PROTEASES  IN  THE AIRWAY 
FOR HUMAN SEASONAL INFLUENZA VIRUSES 
 
Figure  1  shows  the  detection  of  mouse-adapted  IAV 
Aich/2/68(H3N2) antigen in airway epithelial cells of mice 
at 2 and 6 days after intranasal infection. The viral antigen 
was initially detected on the cilia of airway epithelial cells at 
day 2 after infection (typically >90% of infected cells were 
ciliated  airway  epithelial  cells  in  the  mouse  bronchus) 
(Figure 1A). Along with the spread of virus infection at day 
6, the virus antigen spread from the ciliated epithelial cells 
to neighboring non-ciliated secretory epithelial cells in the 
bronchus and was detectable in the whole cell but sparing 
the  nucleus  (Figure  1B).  The  comb-like  structure  of 
epithelial  cells  cilia  became  swollen,  forming  fused-
structures at day 6 after viral infection (Figure 1C and 1D), 
which subsequently fell off. 
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Figure 1. Immunofluorescence detection of mouse-adapted 
human IAV Aichi/2/68(H3N2) in vivo after infection of mice for 
2 days (A) and 6 days (B). C57BL/6 female mice weighing 10-12 
g were instilled intranasally with 6.6 × 10
4 PFU of mouse-
adapted human IAV. Two and 6 days after infection, mouse 
bronchi were isolated, fixed and immunostained for virus HA 
antigen (green). C and D: Scanning electron micrographs of the 
surface of bronchus of mice before (C) and (D) 6 days after IAV 
infection. Cilia of airway epithelial cells of female mouse with a 
comb-like structure before virus infection became swollen, 
forming fused-structures at 6 days after intranasal IAV infection 
and many of such cilia subsequently fell off. Bar = 1 µm.   
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The HA0 processing proteases reported for human IAV in 
animals and humans that recognize single basic motif are 
pancreatic trypsin (Klenk et al, 1975), plasmin from calf and 
chicken  serum  (Lazarowitz  et  al,  1973),  blood  clotting 
factor Xa from chick embryo (Gotoh et al, 1990), tryptase 
Clara from rat lungs (Kido et al, 1992), mini-plasmin from 
rat lungs (Murakami et al,  2001), ectopic anionic trypsin 
from  rat  lungs  (Towatari  et  al,  2002),  porcine  mast  cell 
tryptase  (Chen  et  al,  2000),  tryptase  TC30  from  porcine 
lungs (Sato et al, 2003) and transmembrane protease serine 
(TMPRSS) 2 and type II membrane protein human airway 
trypsin-like protease (HAT) (Böttcher et al, 2006) (Table 1). 
Why various trypsin-type HA0 processing proteases capable 
of  potentiating  IAV  infections  exist  in  the  airways?  We 
found  different distribution for these cellular  proteases  in 
the  airways  (Kido  et  al,  2007)  as  well  as  different 
proteolytic  potentiation  of  various  strains  of  the  viruses 
(Murakami  et  al,  2001).  Among  the  proteases  we  have 
examined, trypsin efficiently activated the infectivity of all 
strains.  Mini-  and  micro-plasmin  activated  almost  all 
strains, though less efficiently than trypsin. Different HA 
cleavability of some of the processing proteases was found 
among  species:  mast  cell  tryptase  from  porcine  lungs 
processed HA0, whereas human and rat mast cell tryptase 
did not (Chen et al, 2000). However, among the reported 
proteases, blood clotting factor Xa from human serum, not 
from  chick  embryo,  hardly  cleaved  HA0  of  IAV 
Aich/2/68(H3N2) without loss of their amidolytic activities 
against  synthetic  peptide  substrates  (Kido  H  et  al, 
unpublished data). In addition to the host cellular proteases, 
microbial  proteases  also  proteolytically  activate  influenza 
virus HA0 in bacterial infection of the airways and may play 
a role in the spread of the virus (Tashiro et al, 1987; Akaike 
and  Maeda,  2000).  Mutational  evolution  of  IAV  HA0  to 
adapt to these host trypsin-type processing proteases in the 
airway allows efficient multiplication of the virus in vivo 
which ultimately increase to becomes epidemic.  
 
HA0  PROCESSING  PROTEASES  FOR  THE 
HIGHLY  PATHOGENIC  AVIAN  INFLUENZA 
VIRUSES 
 
To-date, all HPAI  viruses of H5 and H7 subtypes have 
cleavage  site  motifs  with  multiple  basic  amino  acids 
(Zambon, 2001; Tsukamoto, 2008) and HA0 of HPAI virus 
is postulated to be cleaved by ubiquitous proteases, such as 
subtilisin-like  proteases,  furin  and  PC5/6  (Klenk  and 
Garten, 1994). In this review, we add a new member of 
type  II  membrane  serine  proteases  on  the  cell  surface, 
other than the subtilisin-like proteases in the trans-Golgi 
network, which recognize and cleave HA0 of HPAI viruses 
with the multiple basic motifs of both R-K/R-(K/R/X)-R 
sequence  with  R  at  position  P4  and  K-K/R-(K/R/X)-R 
sequence with K at position P4. 
 
 
Table 1. Comparison of viral activating enzymes  
 
Enzyme 
MW (kDa) 
SDS-
PAGE 
MW (kDa) Non-
reducing condition 
(composition) 
Optimal 
substrate 
Inhibitor  Localization  Reference 
Tryptase Clara  30   180 (hexamer)  QAR 
aprotinin, leupeptin, 
antipain, KSTI 
bronchiolar epithelial 
Clara cells 
Kido et al., 
1992 
Mini-plasmin  28 + 12   38 (heterodimer)  QAR 
aprotinin, KSTI, BBSTI, 
leupeptin 
folded epithelial cells 
in bronchiolar 
divisions 
Murakami et al., 
2001 
Ectopic anionic 
trypsin I 
22   31 (monomer) 
EGR 
QGR 
aprotinin, soybean trypsin 
inhibitor, leupeptin 
stromal cells in peri-
bronchiolar region 
Towatari et al., 
2002 
Mast cell 
tryptase 
32-35   120 (tetramer)  QAR  antipain, leupeptin  mast cells 
Chen et al., 
2000 
Tryptase TC30  30   30 (monomer)  SIQSR 
aprotinin, benzamidine, 
leupeptin 
ND  Sato et al., 2003 
HAT  28   28 (monomer)  FSR 
aprotinin, leupeptin, 
antipain, KSTI 
ciliated epithelial cells 
Yasuoka et al., 
1997 
TMPRSS2  70 (32) 
70 (32 kDa: released 
form) (monomer) 
GGR 
Benzyloxycarbonyl lysine 
dephenylphosphonate 
Epithelial cells of 
respiratory, 
gastrointestinal, and 
urogenital tracts 
Wilson et al., 
2005 
 
HAT: type II membrane protein human airway trypsin-like protease; TMPRSS2: transmembrane protease serine 2; M.W.: molecular weight, KSTI; 
Kunitz-type soybean trypsin inhibitor; BBSTI: Bowman-Birk soybean trypsin inhibitor; ND: Not determined.  
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The cleavage preferences of subtilisin-like proteases, furin, 
PC4, PC5/6, PC7, PACE4, are R at P1 and P4 positions in 
the cleavage motif R-X-(R/K/X)-R and replacement of P4 R 
by  K and a  nonbasic amino  acid  significantly suppresses 
their  processing  activity  (Bently  et  al,  1986;  Barr  1991; 
Thomas 2002; Remacle et al, 2008). These subtilisin-like 
proteases  are  calcium-dependent  with  a  pH  optimum 
ranging from 6.5 to 7.5 (Stieneke-Gröber et al, 1992) and 
are  mainly  localized  intracellularly  in  the  trans-Golgi 
network and some cycle between the trans-Golgi and the 
cell  surface  membrane  (Thomas,  2002).  The  relationship 
between the pathogenesis of HPAI viruses and proteolytic 
HA0 cleavage of the multiple basic residue motif with R at 
P1  and  P4  positions  has  been  studied  extensively  (see 
reviews  by  Zambon,  2001;  Stieneke-Gröber  et  al,  1992; 
Walker  et  al,  1994;  Shiryaev  et  al,  2007).  In  the  HPAI 
viruses,  however,  there  is  another  type  of  HA0  cleavage 
sequence with multi-basic cleavage motif with R at P1 and 
K at P4, which is not a preferable or not a substrate of furin. 
 
Type  II  membrane  serine  proteases  (TTSP)  of  mosaic 
serine protease large form (MSPL) and its splice variant 
transmembrane protease serine 13 (TMPRSS13) with a pH 
optimum  ranging  from  7.0  to  8.5  and  no  calcium 
requirement,  are  identified  as  new  candidate  HA0 
processing proteases for HAPI virus on the cell surface. 
MSPL and TMPRSS13 were recently cloned from human 
lungs  (Kim  et  al,  2001;  Kido  and  Okumura,  2008). 
Although  furin  selectively  cleaves  the  multiple  basic 
residues motif with R at P1 and P4, these novel membrane 
proteases  preferentially  recognize  the  double  basic 
residues at the cleavage site, and R or K at P4 position in 
the  multiple  basic  residues  motifs  greatly  enhances  the 
efficiency of processing. 
 
Figure 2 shows alignment of the amino acid sequences of 
MSPL  with  581  residues  and  TMPRSS13  with  567 
residues  and  schematic  representation  of  the  domain 
structure of MSPL. The serine protease domains at residues 
321–581  for  MSPL  and  326–567  for  TMPRSS13  are 
identical except for the C-terminal ends, i.e., 555–581 for 
MSPL  and  560–567  for  TMPRSS13  (Figure  2A).  They 
have a typical catalytic triad (His, Asp and Ser) of serine 
proteases, and a putative proteolytic activation site (R) in 
the  R
320-I-V-G-G
324  in  MSPL  and  R
325-I-V-G-G
329  in 
TMPRSS13.  The  consensus  protease  domain  of 
MSPL/TMPRSS13 exhibits 42, 39 and 43% identity with 
those of human plasma kallikrein (Beaubien et al, 1991), 
hepsin  (Tsuji  et  al,  1991),  and  transmembrane  protease 
serine  2  (TMPRSS2)  (Paoloni-Giacobino  et  al,  1997), 
respectively,  but  poor  identity  with  subtilisin  family 
protease  furin.  MSPL  and  TMPRSS13  have  putative 
transmembrane  domains  (P
162–W
184  and  P
167–W
189, 
respectively)  at  the  N-terminal  sides.  The  cytoplasmic 
domain  of  these  variants  has  tandem  repeat  motifs 
corresponding  to  the  phosphorylation  sites  of  cyclin-
dependent kinase Cdc2, CaM kinase II and protein kinase 
C (Kennelly and Krebs, 1991; Wang and Roach, 1993), and 
is the longest among the TTSPs known to date (Figure 2B). 
 
The  expression  profiles  of  MSPL  and  TMPRSS13  in 
various  human  tissues  and  cells  assessed  by  reverse 
transcription-polymerase  chain  reaction  (RT-PCR)  with 
specific  primer  pairs  for  each  C-terminal  of  the  serine 
protease domains (Figure 3A and B), show that both genes 
are  predominantly  expressed  in  human  lung,  placenta, 
pancreas  and  prostate,  although  TMPRSS13  is  almost 
ubiquitously expressed in various organs except a limited 
expression  in  skeletal  muscle.  TMPRSS13/MSPL  are 
expressed  at  high  levels  in  blood  vessels,  human 
choriocarcinoma (BeWo) cells and human umbilical vein 
endothelial  cells  (HUVEC)  in  primary  cultures,  but  not 
detectable  in  human  endothelial  cell  line  ECV-304, 
although furin is  detectable  in  almost all  human  organs 
and  the  cells  examined,  including  ECV-304  (data  not 
shown).  The  high  expression  of  chicken  TMPRSS13 
(cTMPRSS13)  is  also  detected  in  blood  vessels,  lungs, 
trachea, colon, small intestines and kidneys (Figure 3C).  
 
The  recombinant  extracellular  regions  of  human  MSPL 
(hMSPL) and hTMPRSS13 (i.e., SRCR domain and serine 
protease domain) after transfection of the constructs into 
HEK 293T cells were purified from the serum-free culture 
medium and then characterized. The substrate specificities 
of the recombinant hMSPL are shown in Table 2. Among 
the  synthetic  substrates  tested,  hMSPL  preferentially 
hydrolyzes dibasic substrates (R/K at P1 and P2 positions) 
and  furin  substrate  L-pyroglutamyl-R-T-K-R-4-
methylcoumaryl-7-amide  (MCA)  with  R  at  P1  and  P4 
being  the  best.  Peptide  substrate  of  HPAI  virus 
A/chick/Penn/1370/83  (H5N2),  M-R-N-V-P-Q-K-K-K-
R↓-G-L-F-G  with  K  at  position  P4  is  also  cleaved  by 
hMSPL  efficiently,  the  activity  being  equivalent  to  the 
furin  substrate.  However,  substrates  with  Lys  at  P1 
position are less hydrolyzed. Unlike trypsin and plasmin, 
Bz-R-MCA and Boc-V-L-K-MCA are not hydrolyzed by 
MSPL and no activity  is observed  on the substrates for 
elastase  and  chymotrypsin-type  proteases.  Recombinant 
hTMPRSS13 shows similar substrate specificity to that of 
hMSPL.  The  active  site  mutants,  hMSPLS506A  and 
hTMPRSS13S511A,  do  not  hydrolyze  any  substrates  at 
all.  The  activity  of  hMSPL  is  inhibited  by  trypsin 
inhibitors, such as aprotinin, benzamidine and Bowman-
Birk  trypsin  inhibitor,  but,  unlike  trypsin,  α1-antitrypsin 
does not inhibit the enzyme activity (Kido and Okumura 
2008).  In  the  furin  inhibitors  tested,  decanoyl-RVKR-
chloromethylketone,  but  not  α1-antitrypsin  Portland, 
inhibits the enzyme activity with a low Ki value of 2.9 nM 
(Okumura  et  al,  submitted).  The  inhibitor  specificity  of 
recombinant hTMPRSS13 is similar to that of hMSPL. 
 
PROTEOLYTIC ACTIVATION OF HA0 OF HIGHLY 
PATHOGENIC  AVIAN  INFLUENZA  VIRUS  BY 
hMSPL AND hTMPRSS13 
 
A large number of HPAI (H5 and H7) viruses has the HA 
cleavage  site  sequence  of  R-K/R-(K/R/X)-R,  which  is 
cleavable by furin, PC5/6, hMSPL and hTMPRSS13. On 
the other hand, part of HPAI viruses has the other cleavage 
site sequence of K-K/R-(K/R/X)-R with K at P4 position. 
To  analyze  the  cleavage  specificities  of  hMSPL  and 
hTMPRSS13 against the motifs of HPAI, we performed 
mass spectrometry analyses of the synthetic HA peptides 
containing  the  cleavage  motif  sequence  and  part  of 
membrane  fusion  domain  G-L-F-G  sequence  at  the  C-
terminal  side,  M-R-N-V-P-Q-K-K-K-R-G-L-F-G  
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(A/chicken/Pennsylvania/1370/83(H5N2)),  and  P-E-P-S-
K-K-R-K-K-R-G-L-F-G  (A/FPV/Rostock/34(H7N1)), 
after incubation with these enzymes for 1 h. Both enzymes 
preferentially cleaved the C-terminal side of R adjacent to 
the G-L-F-G sequence. There was no significant difference 
in  cleavage  efficiency  by  hMSPL  and  hTMPRSS13 
between  the  peptide  M-R-N-V-P-Q-K-K-K-R-G-L-F-G 
with K at P4 position and P-E-P-S-K-K-R-K-K-R-G-L-F-
G  with  R  at  P4  position  (Okumura  et  al,  submitted). 
Similar results were obtained in the experiments of eight 
different  synthetic  peptides  with  K/R  at  P4  from  HPAI 
viruses. 
 
 
 
A: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Alignment of amino acid sequences of hMSPL and hTMPRSS13 and schematic representation of the domain structures of 
hMSPL. (A) Alignment of the amino acid sequences of hMSPL and hTMPRSS13. Numbering starts with Met
1 of the first amino 
acid. The putative transmembrane domain is bold-underlined. Arrow points to the putative cleavage site for active serine protease. 
The catalytic triad (His, Asp and Ser) are indicated by arrowheads. Potential N-glycosylation sites are indicated by closed diamonds. 
hTMPRSS13 differs from hMSPL by the 5-amino acid insertion in the tandem repeat sequences (from Gln
83 to Ala
87) and the 8-
amino acid extension at the C-terminus (from Ser
560 to Ser
567) (asterisks). (B) Schematic representation of predicted domain structure 
of hMSPL. TM, transmembrane domain; SRCR, scavenger receptor cysteine-rich domain; SPD, serine protease domain. The putative 
kinase phosphorylation sites found in the N-terminal side tandem repeat sequence. The sequence motifs matching the consensus 
sequences, such as S/T-P-X-K/R of Cdc2, R-X-X-S/T of CaM kinase II and R-X-X-S-X-R of protein kinase C, are in boldface. 
Homologous sequences, ASPA, are underlined.  
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Figure 3. Gene expression profiles of hMSPL and hTMPRSS13 in various human tissues (A), cells (B) and those of cTMPRSS13 
(C). RT-PCR analysis was carried out using MSPL- and TMPRSS13-specific primers in the indicated tissues and cells. As a 
template, Human Multiple Tissue cDNA Panels were used. The expression level of GAPDH mRNA in each sample was used as an 
internal control. HUVEC; human umbilical vein endothelial cells. 
 
 
For  exo  vivo  experiments,  we  established  full-length 
human  MSPL  and  TMPRSS13  stable  transfectant  ECV-
304  cells,  ECV304-MSPL  and  ECV304-TMPRSS13, 
respectively. Since recombinant HA expression system of 
HPAI  virus  with  the  K-K-K-R  cleavage  site  is  not 
currently available in spite of various trials, we used in the 
following  experiments  the  expression  of  highly  virulent 
influenza A/chick/Penn/1/83 (H5N2) variant 47 (Ohuchi et 
al, 1989) as an example of poor-susceptible strain to furin. 
This  variant  has  R-K-K-R  cleavage  motif  but  poor 
cleavage  susceptibility  to  furin.  After  infection  of 
ECV304-MSPL, ECV304-TMPRSS13 cells and wild-type 
ECV304  (ECV304-WT)  cells  with  the  A/chicken/ 
Penn/1/83 (H5N2) variant 47 HA/SV40 recombinant virus 
for 48 h, HA cleavage efficiencies and cell fusion activity 
monitored  by  giant  cell  formation  were  analyzed.  The 
recombinant HA0 in ECV304-WT cells was converted to 
HA1  subunit  with  low  efficiency  of  9-14%,  although 
higher conversion rates of 37-42% were observed in both 
ECV304-MSPL and ECV304-TMPRSS13 cells (Okumura 
et  al,  submitted).  On  the  other  hand,  furin-susceptible 
recombinant  H7  HA0  with  R-K-K-R  motif  showed  40-
45%  conversion  in  WT  and  MSPL/TMPRSS13-
transfectant  cells  after  infection  with  the 
A/FPV/Rostock/34  H7  HA/SV40  recombinant  virus 
(Ohuchi  et  al.  1994)  under  the  same  experimental 
conditions. The proteolytically activated recombinant HA0 
of  HPAI  viruses  facilitated  cell  fusion.  These  results 
suggest that MSPL and TMPRSS13 are novel candidate 
HA0 processing proteases for HPAI viruses, in addition to 
furin and PC5/6. 
 
UPREGULATION  BY  INFECTION  OF  LATENT 
PANCREATIC TRYPSIN IN VARIOUS ORGANS 
 
Most of the epidemic human IAV are pneumotropic but a 
few neurotropic strains can multiply both in the airway and 
brain.  In  addition,  a  rare  but  often  fatal  encephalopathy 
caused  by  infection  with  a  pneumotropic  IAV  has  been 
reported in children with Reye’s syndrome and influenza-
associated encephalopathy (Delorme and Middleton 1979; 
Fujimoto  et  al,  1998).  Recently,  we  reported  that  IAV 
infection can markedly upregulate latent pancreatic trypsin 
in the brain (Le et al, 2006) and various organs that may 
have not only a HA0 processing activity but also a maturase 
activity  of  upregulated proMMP-9 (Yamada et al, 2006). 
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Figure 4 shows the localization of brain trypsin I determined 
by  in  situ  hybridization.  The  results  showed  that  this 
enzyme clusters in the hippocampal pyramidal and dentate 
gyrus neuronal cells and also distributes in endothelial cells 
of the brain capillaries, particularly in the allocortex. The 
enzyme  distribution  pattern  supports  the  accumulation  of 
neurovirulent  IAV  WSN(H1N1)  antigen  in  hippocampal 
neuronal  cells  (Takahashi  et  al,  1995)  and  that  of 
pneumotropic IAV Aichi/2/68(H3N2) antigen in the brain 
capillaries  (Yao et  al,  2006).  Upregulation  of proMMP-9 
and its convertase trypsin seems to synergistically enhance 
the destruction of basement membrane component type IV 
collagen  and  endothelial  cell  tight  junction  components, 
resulting in sever edema and connective tissue damage in 
various organs.  
 
To provide evidence for the roles of cellular proteases in 
influenza virus infection, phenotype analyses of trypsin I 
knockout  mouse  and  TMPRSS13  knockout  mouse  after 
influenza virus infection are now under investigations. 
 
 
Table 2. Substrate specificities of recombinant soluble hMSPL 
 
Substrate (100 µ µ µ µM)  Relative activity (%) 
Boc-Q-A-R-MCA  100.0±1.8 
Pyr-R-T-K-R-MCA 
M-R-N-V-P-Q-K-K-K-R↓ 
-G-L-F-G 
3620.7±21.6 
3312.1±43.2 
Boc-Q-R-R-MCA  707.7±5.9 
Boc-R-V-R-R-MCA  667.4±5.2 
Boc-L-R-R-MCA  350.0±2.3 
Boc-L-K-R-MCA  192.3±1.9 
Boc-E-K-K-MCA  57.8±0.8 
Boc-E(OBzl)-A-R-MCA  66.7±1.1 
Boc-L-S-T-R-MCA  46.7±0.3 
Boc-F-S-R-MCA  33.3±0.2 
Boc-Q-G-R-MCA  20.0±0.2 
Boc-L-T-R-MCA  18.9±0.1 
P-F-R-MCA  12.2±0.1 
Boc-E(OBzl)-G-R-MCA  11.1±0.1 
Boc-V-L-K-MCA  0.0±0.0 
Bz-R-MCA  0.0±0.0 
Suc-A-P-A-MCA  0.0±0.0 
Suc-A-A-P-F-MCA   0.0±0.0 
The amidolytic activities of the purified hMSPL were analyzed 
toward various synthetic peptides in 0.1 M Tris-HCl (pH 8.0) at 
37°C. The amount of 7-amino-4-methylcoumarin and the C-
terminal fragment peptide liberated from the substrate were 
determined. One unit of enzyme activity was defined as the 
amount that degraded 1 µmol of substrate per min. Data are mean 
± SD of three separate experiments and are expressed as 
percentages of activity toward Boc-Q-A-R-MCA.  
 
 
CONCLUSIONS  
 
Cellular HA0 processing enzymes are prerequisite for the 
infectivity  and  pathogenicity  of  human  IAV  and  HPAI 
viruses. In addition, IAV-induced trypsin and proMMP-9 
causes further tissue damage. Anti-influenza virus drugs, 
inhibitors  of  viral  neuraminidase,  are  going  to  be 
stockpiled in many countries as part of their anti-pandemic 
planning.  However,  adverse  effects  have  recently  been 
observed  from  its  therapeutic  or  prophylactic 
administration (Nicholson et al, 2000), including reports of 
increasingly  frequent  neuraminidase  inhibitor  resistant 
virus (Kiso et al, 2004). To prevent the emergence of drug-
resistant mutants and to improve the therapeutic potential 
of these drugs, the combined use of several anti-viral drugs 
with  different  modes  of  action  seems  preferable.  One 
promising  candidate  anti-influenza  drug  could  be 
inhibitors  of  cellular  processing  proteases  of  viral 
envelope fusion glycoprotein precursor HA0, which inhibit 
viral entry into cells. The other strategy is inhibition of up-
regulation  of  trypsin  and  proMMP-9,  which  might  be 
useful to prevent tissue damage in various organs. 
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LIST OF ABBREVIATIONS 
 
Boc: t-Butyloxycarbonyl 
Bz: Benzoyl 
GAPDH: Glyceraldehyde-3-phosphate dehydrogenase 
HUVEC: Human umbilical vein endothelial cell 
HA0: Hemagglutinin precursor 
HAT: Human airway trypsin-like protease 
HPAI: Highly pathogenic avian influenza A virus 
IAV: Influenza A virus 
MCA: Methylcoumaryl-7-amide 
MMP-9: Matrix metalloprotease-9 
MSPL: Mosaic serine protease large form 
PC: Proprotein convertase 
TMPRSS: Transmembrane protease serine 
TTSP: Type II membrane serine protease  
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Figure 4. In situ hybridization of trypsin I in rat brain. Low-power photomicrographs of rat brain section, hybridized with rat trypsin 
I antisense probe (A) and sense probe (B). Bars in A and B represent 1 mm. High power photographs of A show that the positive 
staining is localized in pyramidal neurons of the cornuammonis (CA)1-2 (C) and CA-3 (D), and in the granular cells of the dentate 
gyrus (DG) (E). Capillary endothelial cells (En) were also heavily stained (D and F). Bars, C, D and E = 100 µm, F = 50 µm. 
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